Abstract
Atherosclerotic renal artery stenosis (ARAS) is a progressive disease and it is usually associated with hypertension as well as with chronic kidney and cardiovascular disease. Although the anatomical lesions are relatively easy to depict, there is need to identify diagnostic methods to establish the functional significance of the stenosis and predict the response to revascularization. Over the last years, renal revascularization appears to be increasingly performed in patients with ARAS. However, controversy abounds as so far prospective, randomised trials did not document any benefit of revascularization with or without stenting plus optimal medical treatment over optimal medical treatment alone. In this review, we discuss the current data in the field of diagnosis and management of patients with ARAS
Keywords: Atherosclerotic renal artery stenosis, renovascular hypertension, diagnosis, management, renal revascularization, cardiovascular disease, coronary heart disease, type 2 diabetes mellitus, aortic aneurysm, angiotensin receptor blocker
Current Vascular Pharmacology
Title: Atherosclerotic Renal Artery Stenosis: An Update on Diagnosis and Management
Volume: 9 Issue: 4
Author(s): Eirini Stavrinou, Charalambos Koumaras, Thomas D. Gossios, Konstantinos Tziomalos, Vasilios G. Athyros and Asterios Karagiannis
Affiliation:
Keywords: Atherosclerotic renal artery stenosis, renovascular hypertension, diagnosis, management, renal revascularization, cardiovascular disease, coronary heart disease, type 2 diabetes mellitus, aortic aneurysm, angiotensin receptor blocker
Abstract: Atherosclerotic renal artery stenosis (ARAS) is a progressive disease and it is usually associated with hypertension as well as with chronic kidney and cardiovascular disease. Although the anatomical lesions are relatively easy to depict, there is need to identify diagnostic methods to establish the functional significance of the stenosis and predict the response to revascularization. Over the last years, renal revascularization appears to be increasingly performed in patients with ARAS. However, controversy abounds as so far prospective, randomised trials did not document any benefit of revascularization with or without stenting plus optimal medical treatment over optimal medical treatment alone. In this review, we discuss the current data in the field of diagnosis and management of patients with ARAS
Export Options
About this article
Cite this article as:
Stavrinou Eirini, Koumaras Charalambos, D. Gossios Thomas, Tziomalos Konstantinos, G. Athyros Vasilios and Karagiannis Asterios, Atherosclerotic Renal Artery Stenosis: An Update on Diagnosis and Management, Current Vascular Pharmacology 2011; 9 (4) . https://dx.doi.org/10.2174/157016111796197251
DOI https://dx.doi.org/10.2174/157016111796197251 |
Print ISSN 1570-1611 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6212 |
Call for Papers in Thematic Issues
TREATMENT OF CARDIOVASCULAR DISEASE IN CHRONIC AND END STAGE KIDNEY DISEASE
Cardiovascular disease still remains the leading cause of death in Chronic and End Stage Kidney Disease, accounting for more than half of all deaths in dialysis patients. During the past decade, research has been focused on novel therapeutic agents that might delay or even reverse cardiovascular disease and vascular calcification, ...read more
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Circadian Rhythm of Blood Pressure in Diabetes Mellitus: Evidence, Mechanisms and Implications
Current Diabetes Reviews Anticoagulation in Patients with Heart Failure
Cardiovascular & Hematological Agents in Medicinal Chemistry Clinical Profile of Patients with Hypertensive Emergency Referred to a Tertiary Hospital in the Western Cape Province of South Africa
Current Hypertension Reviews Endothelial Dysfunction and Coronary Atherosclerosis
Current Drug Targets - Cardiovascular & Hematological Disorders Vulnerable Plaque and Inflammation: Potential Clinical Strategies
Current Pharmaceutical Design Nutrition Transition and Obesity Among Teenagers and Young Adults in South Asia
Current Diabetes Reviews Prevention of Cardiovascular Diseases with Anti-Inflammatory and Anti- Oxidant Nutraceuticals and Herbal Products: An Overview of Pre-Clinical and Clinical Studies
Recent Patents on Inflammation & Allergy Drug Discovery Severe Hyponatremia and Other Electrolyte Disturbances Associated with Indapamide
Current Drug Safety Adynamic Ileus Induced by Varenicline
Current Drug Safety Pathophysiology and Prevention of Bronchopulmonary Dysplasia
Current Pediatric Reviews The Management of Membranous Glomerulopathy in Allogeneic Stem Cells Transplantation: Updated Literature
Cardiovascular & Hematological Agents in Medicinal Chemistry Bioactivity of American Ginseng by Knockout Extract Preparation Using Monoclonal Antibody
Current Drug Discovery Technologies Deaths Due to Cardiomyopathy of Unknown Etiology in Children and Young Adults
Current Forensic Science ISCHEMIRs: Finding a Way Through the Obstructed Cerebral Arteries
Current Drug Targets Modifiable Risk Factors for Dementia: The Role of Gut Microbiota
Current Alzheimer Research Marine Food Protection in Testicular Damages Caused by Diabetes Mellitus
Current Diabetes Reviews Essential Hypertension: Translating Pathophysiology into Pharmacogenomics
Current Pharmacogenomics Detection of Obstructive Sleep Apnea Using Internet of Things: A Review
International Journal of Sensors, Wireless Communications and Control Top Three Pharmacogenomics and Personalized Medicine Applications at the Nexus of Renal Pathophysiology and Cardiovascular Medicine
Current Pharmacogenomics and Personalized Medicine Comparative Effect of Telmisartan vs Lisinopril on Blood Pressure in Patients of Metabolic Syndrome
Endocrine, Metabolic & Immune Disorders - Drug Targets